skip to main content
About Us
Who We Are
Our Ambition, Purpose, & Values
Executive Leadership Team
Board of Directors
Our Locations
Contact Us
Products
Gastrointestinal
Dermatology Products/Aesthetics Devices
International Pharmaceuticals
Generics, Neurology and Other
Dentistry
Vision Care
U.S. Product List
R & D
Our Pipeline
ESG
Ethics and Compliance Program
U.S. Health Care Compliance Policy
Declaration of Compliance
Misconduct Reporting Mechanisms
Auditing, Monitoring and Risk Assessments
Training and Awareness
Policies and Procedures
Compliance Governance
U.S. Grants
Payments to U.S. Health Care Professionals
Charitable Contributions
Education and Research Grants
U.S. Assistance Programs
Patient Assistance Programs
Responsible Procurement
Safety and Quality
Global Quality Management System (GQMS)
Public Reporting on Product and Service Safety Issues
Safety Data Sheets
Responsible Clinical Trials
Investors
INVESTOR RELATIONS HOME
Stock Information
Stock Chart
Historical Price Lookup
Investment Calculator
Advanced Fundamentals
Analyst Coverage
Annual Reports Archive
Corporate Governance
Board of Directors
SEC Filings
Corporate Governance Documents
News Releases
Events and Presentations
Investor Information
Financial Tear Sheet
Shareholder Services
IR and Communications Contacts
NewsRoom
News Releases
Careers
Working at Bausch Health
Benefits
Our U.S. Businesses
Job Search
About Us
Who We Are
Our Ambition, Purpose, & Values
Executive Leadership Team
Board of Directors
Our Locations
Contact Us
Products
Gastrointestinal
Dermatology Products/Aesthetics Devices
International Pharmaceuticals
Generics, Neurology and Other
Dentistry
Vision Care
U.S. Product List
R & D
Our Pipeline
ESG
Ethics and Compliance Program
U.S. Health Care Compliance Policy
Declaration of Compliance
Misconduct Reporting Mechanisms
Auditing, Monitoring and Risk Assessments
Training and Awareness
Policies and Procedures
Compliance Governance
U.S. Grants
Payments to U.S. Health Care Professionals
Charitable Contributions
Education and Research Grants
U.S. Assistance Programs
Patient Assistance Programs
Responsible Procurement
Safety and Quality
Global Quality Management System (GQMS)
Public Reporting on Product and Service Safety Issues
Safety Data Sheets
Responsible Clinical Trials
Investors
INVESTOR RELATIONS HOME
Stock Information
Stock Chart
Historical Price Lookup
Investment Calculator
Advanced Fundamentals
Analyst Coverage
Annual Reports Archive
Corporate Governance
Board of Directors
SEC Filings
Corporate Governance Documents
News Releases
Events and Presentations
Investor Information
Financial Tear Sheet
Shareholder Services
IR and Communications Contacts
NewsRoom
News Releases
Careers
Working at Bausch Health
Benefits
Our U.S. Businesses
Job Search
Home
»
Investor Relations
»
News Releases
»
2025
Share
facebook
googleplus
twitter
linkedin
2025
Register for email alerts
.
All Categories
All Categories
AGM
Products
IPO
Organization
Financial
2025
2024
2023
2022
2021
2020
2019
2018
Archive
2025
2025
2024
2023
2022
2021
2020
2019
2018
Archive
Date
Title
Document
Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference
Date
02/14/25
Title
Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference
Download
pdf
Bausch Health Announces 2025 Salix Gastrointestinal Health Scholars Program
Date
02/10/25
Title
Bausch Health Announces 2025 Salix Gastrointestinal Health Scholars Program
Download
pdf
Bausch Health Provides Update on Strategic Alternatives
Date
02/06/25
Title
Bausch Health Provides Update on Strategic Alternatives
Download
pdf
Bausch Health to Announce Fourth Quarter and Full Year 2024 Results on February 19, 2025
Date
01/23/25
Title
Bausch Health to Announce Fourth Quarter and Full Year 2024 Results on February 19, 2025
Download
pdf
Bausch Health Statement on Selection of XIFAXAN® (rifaximin) for Inflation Reduction Act’s Medicare Negotiation Program
Date
01/17/25
Title
Bausch Health Statement on Selection of XIFAXAN® (rifaximin) for Inflation Reduction Act’s Medicare Negotiation Program
Download
pdf
NYSE:BHC
TSX: BHC